Unife has signed the renewal of the CRUI-ACS (American Chemical Society) transformative agreement 2024-2026, a renewal finalized only in December 2025 although the previous agreement expired in December 2023.
The renewal allows for:
- access to the contractual journals through the ACS Publications platform, from the university's network, or from a connection outside the Unife LAN using the OpenVPN software;
- unlimited publication for Unife authors in hybrid and fully gold journals included in the CRUI-ACS transformative agreement.
The contract defines an Eligible Author for OA requests as someone who, cumulatively:
- is primarily affiliated with an adhering Institution (in the case of articles published by multiple authors, only the submitting author can be considered the Affiliated Author);
- has signed the OA publication agreement;
- has been confirmed as an Affiliated Author by an Institution.
If the corresponding author, i.e. the Unife researcher in charge of submitting the article (it is recommended to always use email address @unife.it), chooses to publish in Open Access, the publication costs (APC) will be charged to the university contract.
The list of journals eligible for OA publication can be found at this link.
Attention: there is no retrospective conversion for articles published under subscription (closed access) in ACS journals in the years prior to 2026; even in the event of conversion, the publisher will not refund expenses incurred and will not return the copyright transferred on the articles to the authors.
At this URL you can find information on the contract signed by the University and other information on publishing open access in this publisher's journals.
TDM activities will be governed by Art. 3 of Directive 2019/790. The European Directive is the standard transposed into Italian law in Art. 70-ter of Law 633/1941. Please see point h) of the attachment on authorized uses of Subscribed Products within this agreement.
Please see the attached 'Authorized Uses' file for uses permitted exclusively for educational research and non-commercial purposes of the subscribed products.
Please see the attached 'Usage Limits' file for limits on the use of subscribed products.
Last update: 10.02.2026